WHO ‘strongly recommends’ Pfizer's Covid-19 pill for at-risk patients: Report
The WHO experts said that US pharma giant Pfizer’s combination of nirmatrelvir and ritonavir was the “superior choice” of treatment for unvaccinated, elderly or immunocompromised people with Covid-19, according to AFP.
Apr 22, 2022, 08:16 AM IST